Pfizer has committed R255 million to the South African pharmaceutical industry
This investment, according to Pfizer, will provide jobs and opportunity for highly qualified health professionals. Pfizer, a multinational pharmaceutical corporation, has announced that through its relationship with the Biovac Institute, it will spend R255 million in South Africa's pharmaceutical sector. Patrick van der Loo, Pfizer's regional president for Africa and the Middle East (AfME), made the news at the Sandton Convention.... Read more »
Posted on : Wednesday , 13th April 2022